VEGFA and ovarian carcinoma: Moreover, DTX is suggested to overcome the recognised VEGF-mediated protective role against Pt-drugs ́ anti-proliferative activity (firstly reported for cisplatin-treated human ovarian carcinoma [47]), therefore enhancing Pd2Spm-induced cell death.